Stock Research for IMMU

IMMU
Current Price

$16.4750


Latest Update: 2018-02-16 16:00:00

High
$ 16.4800
Low
$ 16.4400
Close
$ 16.4700
Volume
108450
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

IMMU Stock Chart & Research Data

The IMMU chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IMMU chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


IMMU Due diligence Resources & Stock Charts

The IMMU stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View IMMU Detailed Price Forecast - CNN Money CNN View IMMU Detailed Summary - Google Finance
Yahoo View IMMU Detailed Summary - Yahoo! Finance Zacks View IMMU Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View IMMU Trends & Analysis - Trade-Ideas Barrons View IMMU Major Holders - Barrons
NASDAQ View IMMU Call Transcripts - NASDAQ Seeking View IMMU Breaking News & Analysis - Seeking Alpha
Spotlight View IMMU Annual Report - CompanySpotlight.com OTC Report View IMMU OTC Short Report - OTCShortReport.com
TradeKing View IMMU Fundamentals - TradeKing Charts View IMMU SEC Filings - Bar Chart
WSJ View Historical Prices for IMMU - The WSJ Morningstar View Performance/Total Return for IMMU - Morningstar
MarketWatch View the Analyst Estimates for IMMU - MarketWatch CNBC View the Earnings History for IMMU - CNBC
StockMarketWatch View the IMMU Earnings - StockMarketWatch MacroAxis View IMMU Buy or Sell Recommendations - MacroAxis
Bullish View the IMMU Bullish Patterns - American Bulls Short Pains View IMMU Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View IMMU Stock Mentions - StockTwits PennyStocks View IMMU Stock Mentions - PennyStockTweets
Twitter View IMMU Stock Mentions - Twitter Invest Hub View IMMU Investment Forum News - Investor Hub
Yahoo View IMMU Stock Mentions - Yahoo! Message Board Seeking Alpha View IMMU Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for IMMU - SECform4.com Insider Cow View Insider Transactions for IMMU - Insider Cow
CNBC View IMMU Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for IMMU - OTC Markets
Yahoo View Insider Transactions for IMMU - Yahoo! Finance NASDAQ View Institutional Holdings for IMMU - NASDAQ


Stock Charts

FinViz View IMMU Stock Insight & Charts - FinViz.com StockCharts View IMMU Investment Charts - StockCharts.com
BarChart View IMMU Stock Overview & Charts - BarChart Trading View View IMMU User Generated Charts - Trading View


Latest Financial News for IMMU

Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference
Posted on Thursday February 15, 2018

MORRIS PLAINS, N.J., Feb. 15, 2018-- Immunomedics, Inc., today announced that Michael Pehl, President and Chief Executive Officer, will participate in a fireside chat at the RBC Capital Markets 2018 Global ...


Fennec Pharma (FENC): The Most Likely Acquisition Target in Healthcare with 200-300% Upside?
Posted on Thursday February 15, 2018

- Fennec Pharma's (FENC) lead drug sodium thiosulfate headed for U.S. FDA review in coming months and will likely be approved imminently based on strong Phase 3 trial results. Could generate $100-$200 ...


Blog Exposure - FDA Accepts Amicus Therapeutics’ NDA for Migalastat for Treatment of Fabry Disease
Posted on Wednesday February 14, 2018

Stock Monitor: Immunomedics Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 14, 2018 / Active-Investors.com has just released a free research report on Amicus Therapeutics, Inc. (NASDAQ: FOLD ...


8 Companies That Could Disappear by 2019
Posted on Tuesday February 13, 2018

Between the energy sector’s turnaround, a major infrastructure spending plan and the upside of sweeping tax cuts for businesses, it feels like nobody can lose. With that as the backdrop, here are the eight major companies most likely to pull a vanishing act in 2018.


Why Investors remained confident on Etsy, Inc. (ETSY), Immunomedics, Inc. (IMMU)?
StockNewsJournal - Feb 16, 2018
Immunomedics, Inc. (NASDAQ:IMMU) ended its day at 16.09 with the rising stream of 0.56% and its total traded volume was 1.81 million shares less than the average volume.
Brokers Watch List: Etsy, Inc. (NASDAQ:ETSY), Immunomedics Inc. (NASDAQ:IMMU) - The Oracle Examiner
Immunomedics (NASDAQ:IMMU) Rating Increased to Buy at BidaskClub - The Lincolnian Online

Immunomedics Inc. (IMMU) Soars 5.6% on January 23
Equities.com - Jan 23, 2018
Immunomedics Inc. (IMMU) had a good day on the market for Tuesday January 23 as shares jumped 5.6% to close at $18.11. About 3.79 million shares traded hands on 19,053 trades for the day, compared with an average daily volume of 3.15 million shares out ...

The Markets Are Undervaluing these stock's: Immunomedics, Inc. (IMMU), Steel ...
StockNewsJournal - Feb 14, 2018
Immunomedics, Inc. (NASDAQ:IMMU) market capitalization at present is $2.46B at the rate of $15.56 a share. The firm's price-to-sales ratio was noted 707.05 in contrast with an overall industry average of 123.30.
Suitable Value Stocks? – Opko Health, Inc. (OPK), Immunomedics, Inc. (IMMU) - Post Analyst

Equities Analysts Issue Forecasts for Immunomedics, Inc.'s Q3 2018 Earnings ...
StockNewsTimes - 11 hours ago
Immunomedics, Inc. (NASDAQ:IMMU) - Stock analysts at Jefferies Group raised their Q3 2018 earnings per share (EPS) estimates for Immunomedics in a research note issued on Wednesday, according to Zacks Investment Research.
Immunomedics (NASDAQ:IMMU) Upgraded to “Buy” by BidaskClub - Dispatch Tribunal
Analysts Set Immunomedics, Inc. (IMMU) Price Target at $21.00 - The Lincolnian Online

Enter a stock symbol to view the stock details.